Prediction Markets Signal Potential Federal Reserve Rate Hike by July 2027 M R Maniveni Foods IPO Allotment Date Expected Today Steps to Check Status Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil Prices to Historic Levels Trump Mobile Probes Potential Data Exposure Affecting Thousands of Prospective Customers London Tour Operators See Shifting Demand From Landmark Tours to HighSpeed Thames Rides Legence Corp LGN Sees Positive Q1 Momentum Source Report Highlights SU Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency Amid Market Challenges Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Advances DTB Q1 2026 Earnings EPS Falls Short of Expectations Amid Flat Market Response CLS Q1 2026 Earnings Beat and Raise as Celestica Delivers Strong EPS Surprise CPSH Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Gap ResMed Inc RMD Q1 2026 Earnings EPS Beat Driven by Strong Operating Leverage Stock Edges Lower Foremost Clean Energy FMST Dips Nearly 3 Key Support Level in Focus Immatics IMTX Gains Ground Biotech Stock Tests Key Resistance at 1196 Oaktree Acquisition Corp III Life Sciences OACC Holds Steady Near 1070 as SPAC Investors Await Transaction Announcement CBRE Group CBRE Slips 14 as Real Estate Sector Faces Mixed Signals Launch Two Acquisition Corp LPBB Trading Near Trust Value as Shares Hold Steady SCHMID Group Warrants SHMDW Decline 7 as Selling Pressure Intensifies Key Support Level in Focus Avidbank Holdings AVBH Inches Higher as Shares Hold Above Key Support Jazz Pharmaceuticals JAZZ Experiences Modest Decline Following Recent RunUp Neumora Therapeutics NMRA Edges Lower as Stock Tests Key Support at 175 K2 Capital Acquisition Rights KTWOR Jump 1579 as Speculation Builds Around Potential Merger Completion Osprey Bitcoin Trust OBTC Holds Steady Near Key Resistance Amid Cryptocurrency Tailwinds Stock Index Futures Rise as AI Momentum and Geopolitical Optimism Fuel Rally ONE Gas Inc OGS Q1 2026 Earnings EPS Misses Estimates Yet Shares Edge Higher Royalty Pharma RPRX Holds Ground Near Midpoint Steady Trading in Tight Range